Lynx1 Capital Management LP, 10% Owner at Neuphoria Therapeutics Inc. (NEUP), bought 1,278,220 shares at $5.14 ($6.6M) on 2025-10-21, disclosed to the SEC on 2025-10-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.14 | 639,110 | $3.3M | 50.0% |
| 2 | $5.14 | 639,110 | $3.3M | 50.0% |
| Total | $5.14 avg | 1,278,220 | $6.6M | 100% |
| Filing → |
| KRRO | BUY | 2026-04-02 | $6K | — | Filing → |
| TCRX | BUY | 2025-12-23 | $218K | — | Filing → |
| CGEM | BUY | 2025-10-21 | $2.5M | — | Filing → |